EN | UA
EN | UA

Help Support

Back

Meta-analysis reveals a 39% reduction in preeclampsia risk with Vitamin D

Preeclampsia Preeclampsia
Preeclampsia Preeclampsia

What's new?

The use of vitamin D has the potential to improve maternal and neonatal health by reducing the incidence of serious pregnancy complications like preeclampsia.

A recent meta-analysis spanning over 19 randomized controlled studies revealed that vitamin D supplementation significantly reduces the risk of preeclampsia in expectant mothers, as published in the European Journal of Integrative Medicine.

Preeclampsia is a concerning complication during gestation, which poses serious health maternal and neonatal risks.

The analysis, conducted by Zainab Alimoradi et al. using a combination of different statistical models, put forward the benefits of vitamin D.

After exploring 5 renowned scientific databases, 19 randomized studies were included. The Cochrane Tool Checklist (CTC) was used to evaluate the methodological grade of these studies. As per the risk ratio (RR), about a 39% reduction in preeclampsia risk among those who received vitamin D compared to their counterparts was observed. Also, the risk difference (RD) highlights a 3% lower risk in the vitamin D-supplemented group, a promising sign for pregnant women.

The number needed-to-treat (NNT) stood at 29. Meaning- For every 29 pregnant women who receive vitamin D supplementation, one case of preeclampsia could be prevented!

Source:

European Journal of Integrative Medicine

Article:

The effect of vitamin D supplementation in pregnancy on the incidence of preeclampsia: A systematic review and meta-analysis

Authors:

Zainab Alimoradi et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: